| Year |
Citation |
Score |
| 2020 |
Velay A, Gallais F, Benotmane I, Wendling MJ, Danion F, Collange O, De Sèze J, Schmidt-Mutter C, Schneider F, Bilbault P, Meziani F, Fafi-Kremer S. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies. Diagnostic Microbiology and Infectious Disease. 98: 115181. PMID 32957073 DOI: 10.1016/J.Diagmicrobio.2020.115181 |
0.346 |
|
| 2020 |
Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L, Staropoli I, Anna F, Souque P, Fernandes-Pellerin S, Jolly N, Renaudat C, Ungeheuer MN, Schmidt-Mutter C, Collongues N, et al. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. Ebiomedicine. 102915. PMID 32747185 DOI: 10.1016/J.Ebiom.2020.102915 |
0.302 |
|
| 2020 |
Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Anglés-Cano E, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Medicine. PMID 32367170 DOI: 10.1007/S00134-020-06062-X |
0.302 |
|
| 2020 |
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F. Neurologic Features in Severe SARS-CoV-2 Infection. The New England Journal of Medicine. PMID 32294339 DOI: 10.1056/Nejmc2008597 |
0.315 |
|
| 2019 |
Botelho-Nevers E, Gagneux-Brunon A, Velay A, Guerbois-Galla M, Grard G, Bretagne C, Mailles A, Verhoeven PO, Pozzetto B, Gonzalo S, Fafi-Kremer S, Leparc-Goffart I, Pillet S. Tick-Borne Encephalitis in Auvergne-Rhône-Alpes Region, France, 2017-2018. Emerging Infectious Diseases. 25: 1944-1948. PMID 31538929 DOI: 10.3201/Eid2510.181923 |
0.325 |
|
| 2019 |
Velay A, Paz M, Cesbron M, Gantner P, Solis M, Soulier E, Argemi X, Martinot M, Hansmann Y, Fafi-Kremer S. Tick-borne encephalitis virus: molecular determinants of neuropathogenesis of an emerging pathogen. Critical Reviews in Microbiology. 1-22. PMID 31267816 DOI: 10.1080/1040841X.2019.1629872 |
0.308 |
|
| 2019 |
Velay A, Solis M, Benotmane I, Gantner P, Soulier E, Moulin B, Caillard S, Fafi-Kremer S. Intravenous Immunoglobulin (IVIg) Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients. Antimicrobial Agents and Chemotherapy. PMID 31160292 DOI: 10.1128/Aac.00393-19 |
0.327 |
|
| 2019 |
Solis M, Gallais F, Velay A, Fafi-Kremer S. Le virus BK et physiopathologie des maladies associées. Virologie (Montrouge, France). 23: 7-22. PMID 31131830 DOI: 10.1684/Vir.2019.0757 |
0.399 |
|
| 2018 |
Domingo-Calap P, Schubert B, Joly M, Solis M, Untrau M, Carapito R, Georgel P, Caillard S, Fafi-Kremer S, Paul N, Kohlbacher O, González-Candelas F, Bahram S. An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides. Plos Pathogens. 14: e1007368. PMID 30335851 DOI: 10.1371/Journal.Ppat.1007368 |
0.383 |
|
| 2017 |
Velay A, Solis M, Barth H, Sohn V, Moncollin A, Neeb A, Wendling MJ, Fafi-Kremer S. Comparison of six commercial tick-borne encephalitis IgM and IgG ELISA kits and the molecular characterization of their antigenic design. Diagnostic Microbiology and Infectious Disease. PMID 29366629 DOI: 10.1016/J.Diagmicrobio.2017.12.012 |
0.327 |
|
| 2017 |
Solis M, Velay A, Porcher R, Domingo-Calap P, Soulier E, Joly M, Meddeb M, Kack-Kack W, Moulin B, Bahram S, Stoll-Keller F, Barth H, Caillard S, Fafi-Kremer S. Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy. Journal of the American Society of Nephrology : Jasn. PMID 29042457 DOI: 10.1681/Asn.2017050532 |
0.36 |
|
| 2017 |
Velay A, Solis M, Kack-Kack W, Gantner P, Maquart M, Martinot M, Augereau O, De Briel D, Kieffer P, Lohmann C, Poveda JD, Cart-Tanneur E, Argemi X, Leparc-Goffart I, de Martino S, ... ... Fafi-Kremer S, et al. A new hot spot for tick-borne encephalitis (TBE): A marked increase of TBE cases in France in 2016. Ticks and Tick-Borne Diseases. PMID 28988602 DOI: 10.1016/J.Ttbdis.2017.09.015 |
0.323 |
|
| 2017 |
Delaine M, Weingertner AS, Nougairede A, Lepiller Q, Fafi-Kremer S, Favre R, Charrel R. Congenital Lymphocytic Choriomeningitis Virus: A Case of Prenatal Diagnosis. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. PMID 28858375 DOI: 10.1002/Jum.14372 |
0.345 |
|
| 2017 |
Delaine M, Weingertner AS, Nougairede A, Lepiller Q, Fafi-Kremer S, Favre R, Charrel R. Microcephaly Caused by Lymphocytic Choriomeningitis Virus. Emerging Infectious Diseases. 23: 1548-1550. PMID 28820372 DOI: 10.3201/Eid2309.170775 |
0.388 |
|
| 2017 |
Gantner P, Velay A, Guigue N, Barth H, Wendling MJ, Delaugerre C, Fafi-Kremer S. Performance of the Liaison® XL Murex recHTLV-I/II Immunoassay in the Detection of HTLV-1/2 Antibodies in Serum. Clinical Laboratory. 63: 997-1001. PMID 28627820 DOI: 10.7754/Clin.Lab.2017.161026 |
0.316 |
|
| 2017 |
Soulie C, Grudé M, Descamps D, Amiel C, Morand-Joubert L, Raymond S, Pallier C, Bellecave P, Reigadas S, Trabaud MA, Delaugerre C, Montes B, Barin F, Ferré V, Jeulin H, ... ... Fafi-Kremer S, et al. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma. The Journal of Antimicrobial Chemotherapy. PMID 28472307 DOI: 10.1093/Jac/Dkx128 |
0.312 |
|
| 2017 |
Velay A, Kack-Kack W, Abravanel F, Lhomme S, Leyendecker P, Kremer L, Chamouard P, Izopet J, Fafi-Kremer S, Barth H. Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient Journal of Neurovirology. 23: 615-620. PMID 28439773 DOI: 10.1007/S13365-017-0525-0 |
0.377 |
|
| 2016 |
Barth H, Solis M, Kack-Kack W, Soulier E, Velay A, Fafi-Kremer S. In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection. Viruses. 8. PMID 27782080 DOI: 10.3390/V8100292 |
0.33 |
|
| 2016 |
Gantner P, Morand-Joubert L, Sueur C, Raffi F, Fagard C, Lascoux-Combe C, Salmon D, Amiel C, Lambert-Niclot S, Fofana DB, Viard JP, Fafi-Kremer S, Rouzioux C, Avettand-Fenoel V, Ghosn J. Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression. The Journal of Antimicrobial Chemotherapy. 71: 751-61. PMID 26676973 DOI: 10.1093/Jac/Dkv395 |
0.312 |
|
| 2016 |
Solis M, Velay A, Porcher R, Domingo-Calap P, Soulier E, Joly M, Meddeb M, Kack-Kack W, Moulin B, Bahram S, Stoll-Keller F, Barth H, Caillard S, Fafi-Kremer S. Anti-BK virus neutralizing antibody titers before transplantation predict BK virus replication in kidney transplant recipients after transplantation Journal of Clinical Virology. 82. DOI: 10.1016/J.Jcv.2016.08.012 |
0.326 |
|
| 2015 |
Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E, Chabaud A, Perrin P, Moulin B, Bahram S, Stoll-Keller F, Caillard S, Barth H, Fafi-Kremer S. Sequence variation in amplification target genes and standards influence interlaboratory comparison of BK virus DNA load measurement. Journal of Clinical Microbiology. PMID 26468499 DOI: 10.1128/Jcm.02145-15 |
0.37 |
|
| 2015 |
Cuzin L, Pugliese P, Sauné K, Allavena C, Ghosn J, Cottalorda J, Rodallec A, Chaix ML, Fafi-Kremer S, Soulié C, Ouka M, Charpentier C, Bocket L, Mirand A, Guiguet M, et al. Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy. Aids (London, England). 29: 1665-71. PMID 26372277 DOI: 10.1097/Qad.0000000000000723 |
0.323 |
|
| 2015 |
Frange P, Assoumou L, Descamps D, Chéret A, Goujard C, Tran L, Gousset M, Avettand-Fenoël V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, et al. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies. The Journal of Antimicrobial Chemotherapy. 70: 2084-9. PMID 25885327 DOI: 10.1093/Jac/Dkv049 |
0.308 |
|
| 2015 |
Lepiller Q, Sueur C, Solis M, Barth H, Glady L, Lefebvre F, Fafi-Kremer S, Schneider F, Stoll-Keller F. Clinical relevance of herpes simplex virus viremia in Intensive Care Unit patients. The Journal of Infection. 71: 93-100. PMID 25749257 DOI: 10.1016/J.Jinf.2015.02.013 |
0.397 |
|
| 2015 |
Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E, Chabaud A, Perrin P, Moulin B, Bahram S, Caillard S, Stoll-Keller F, Fafi-Kremer S. Interlaboratory comparison of BK virus DNA load assays Journal of Clinical Virology. 70. DOI: 10.1016/J.Jcv.2015.07.264 |
0.397 |
|
| 2014 |
Sueur C, Solis M, Meddeb M, Soulier E, Domingo-Calap P, Lepiller Q, Freitag R, Bahram S, Caillard S, Barth H, Stoll-Keller F, Fafi-Kremer S. Toward standardization of BK virus monitoring: evaluation of the BK virus R-gene kit for quantification of BK viral load in urine, whole-blood, and plasma specimens. Journal of Clinical Microbiology. 52: 4298-304. PMID 25297334 DOI: 10.1128/Jcm.02031-14 |
0.343 |
|
| 2014 |
Marrão G, Habib M, Paiva A, Bicout D, Fallecker C, Franco S, Fafi-Kremer S, Simões da Silva T, Morand P, Freire de Oliveira C, Drouet E. Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response. Bmc Cancer. 14: 665. PMID 25213133 DOI: 10.1186/1471-2407-14-665 |
0.363 |
|
| 2013 |
Lepiller Q, Barth H, Lefebvre F, Herbrecht R, Lutz P, Kessler R, Fafi-Kremer S, Stoll-Keller F. High incidence but low burden of coronaviruses and preferential associations between respiratory viruses. Journal of Clinical Microbiology. 51: 3039-46. PMID 23850954 DOI: 10.1128/Jcm.01078-13 |
0.382 |
|
| 2013 |
Schvoerer E, Moenne-Loccoz R, Murray JM, Velay A, Turek M, Fofana I, Fafi-Kremer S, Erba AC, Habersetzer F, Doffoël M, Gut JP, Donlin MJ, Tavis JE, Zeisel MB, Stoll-Keller F, et al. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization. The Journal of Infectious Diseases. 207: 1306-15. PMID 23335805 DOI: 10.1093/Infdis/Jit032 |
0.401 |
|
| 2013 |
Habersetzer F, Moenne-Loccoz R, Meyer N, Schvoerer E, Simo-Noumbissie P, Dritsas S, Stoll-Keller F, Fafi-Kremer S, Baumert TF, el MD. 413 AGE AND THE INACTIVE HBsAg CARRIER STATE ARE PREDICTIVE OF HBsAg LOSS IN A “REAL-LIFE” COHORT OF PATIENTS WITH CHRONIC HBV INFECTION Journal of Hepatology. 58. DOI: 10.1016/S0168-8278(13)60415-8 |
0.304 |
|
| 2012 |
Fafi-Kremer S, Fauvelle C, Felmlee DJ, Zeisel MB, Lepiller Q, Fofana I, Heydmann L, Stoll-Keller F, Baumert TF. Neutralizing antibodies and pathogenesis of hepatitis C virus infection. Viruses. 4: 2016-30. PMID 23202451 DOI: 10.3390/V4102016 |
0.415 |
|
| 2012 |
Lambotin M, Barth H, Moog C, Habersetzer F, Baumert TF, Stoll-Keller F, Fafi-Kremer S. Challenges for HCV vaccine development in HIV-HCV coinfection. Expert Review of Vaccines. 11: 791-804. PMID 22913257 DOI: 10.1586/Erv.12.52 |
0.328 |
|
| 2012 |
Lacek K, Vercauteren K, Grzyb K, Naddeo M, Verhoye L, Słowikowski MP, Fafi-Kremer S, Patel AH, Baumert TF, Folgori A, Leroux-Roels G, Cortese R, Meuleman P, Nicosia A. Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice. Journal of Hepatology. 57: 17-23. PMID 22414763 DOI: 10.1016/J.Jhep.2012.02.018 |
0.379 |
|
| 2011 |
Zeisel MB, Fofana I, Fafi-Kremer S, Baumert TF. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. Journal of Hepatology. 54: 566-76. PMID 21146244 DOI: 10.1016/J.Jhep.2010.10.014 |
0.396 |
|
| 2011 |
Carolla P, Fofana I, Fafi-Kremer S, Zahid M, Cury K, Turek M, Bastien-Valle M, Cosset F, Pietschmann T, Hayer J, Combet C, Habersetzer F, Doffoël M, Keck Z, Foung S, et al. 784 CELL ENTRY FACTOR USAGE AND VIRAL EVASION IN HEPATITIS C VIRUS INFECTION IN VIVO Journal of Hepatology. 54: S315. DOI: 10.1016/S0168-8278(11)60786-1 |
0.408 |
|
| 2010 |
Fafi-Kremer S, Habersetzer F, Baumert TF. Hepatitis C virus entry and glucocorticosteroids. Journal of Hepatology. 53: 1148-50. PMID 20801539 DOI: 10.1016/J.Jhep.2010.07.007 |
0.369 |
|
| 2010 |
Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, Patel AH, Cosset FL, Pessaux P, Doffoël M, Wolf P, Stoll-Keller F, Baumert TF. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. The Journal of Experimental Medicine. 207: 2019-31. PMID 20713596 DOI: 10.1084/Jem.20090766 |
0.393 |
|
| 2010 |
Fofana I, Krieger SE, Grunert F, Glauben S, Xiao F, Fafi-Kremer S, Soulier E, Royer C, Thumann C, Mee CJ, McKeating JA, Dragic T, Pessaux P, Stoll-Keller F, Schuster C, et al. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. Gastroenterology. 139: 953-64, 964.e1-4. PMID 20685314 DOI: 10.1053/J.Gastro.2010.05.073 |
0.379 |
|
| 2010 |
Keymeulen B, Candon S, Fafi-Kremer S, Ziegler A, Leruez-Ville M, Mathieu C, Vandemeulebroucke E, Walter M, Crenier L, Thervet E, Legendre C, Pierard D, Hale G, Waldmann H, Bach JF, et al. Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood. 115: 1145-55. PMID 20007541 DOI: 10.1182/Blood-2009-02-204875 |
0.646 |
|
| 2010 |
Kremer S, Matern JF, Bilger K, Lioure B, Fornecker Y, Stoll-Keller F, Namer IJ, Dietemann JL, Fafi-Kremer S. EBV limbic encephalitis after allogenic hematopoietic stem cell transplantation. Journal of Neuroradiology. Journal De Neuroradiologie. 37: 189-91. PMID 19959232 DOI: 10.1016/J.Neurad.2009.10.001 |
0.325 |
|
| 2010 |
Fofana I, Krieger S, Grunert F, Glauben S, Soulier E, Xiao F, Royer C, Fafi-Kremer S, Schuster C, Thompson J, Baumert TF. 113 Monoclonal Anti-Claudin 1 Antibodies For Prevention Of Hepatitis C Virus Re-Infection In Liver Transplantation Journal of Hepatology. 52. DOI: 10.1016/S0168-8278(10)60115-8 |
0.356 |
|
| 2009 |
Zeisel MB, Fafi-Kremer S, Robinet E, Habersetzer F, Baumert TF, Stoll-Keller F. Adaptive immunity to hepatitis C virus. Viruses. 1: 276-97. PMID 21994550 DOI: 10.3390/V1020276 |
0.369 |
|
| 2009 |
Amiel C, Legoff J, Lescure FX, Coste-Burel M, Deback C, Fafi-Kremer S, Gueudin M, Lafon ME, Leruez-Ville M, Mengelle C, Payan C, Pillet S. Epstein-Barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: a French national cross-sectional study. Journal of Acquired Immune Deficiency Syndromes (1999). 50: 427-9. PMID 19322036 DOI: 10.1097/Qai.0B013E31819A22Ec |
0.331 |
|
| 2009 |
Stoll-Keller F, Barth H, Fafi-Kremer S, Zeisel MB, Baumert TF. Development of hepatitis C virus vaccines: challenges and progress. Expert Review of Vaccines. 8: 333-45. PMID 19249975 DOI: 10.1586/14760584.8.3.333 |
0.383 |
|
| 2009 |
Pastor R, Habersetzer F, Fafi-Kremer S, Doffoel M, Baumert TF, Gut JP, Stoll-Keller F, Schvoerer E. Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World Journal of Gastroenterology. 15: 753-5. PMID 19222103 DOI: 10.3748/Wjg.15.753 |
0.347 |
|
| 2009 |
Stoll-Keller F, Argy N, Heranney N, Gut JP, Fafi-Kremer S. P.068 Use of a respiratory virus panel test for the diagnosis of viral respiratory infections: impact of rhinoviruses Journal of Clinical Virology. 44. DOI: 10.1016/S1386-6532(08)70131-8 |
0.379 |
|
| 2009 |
Moenne-Loccoz R, Rajafinjatovo C, Fafi-Kremer S, Habersetzer F, Ananna A, Doffoël M, Baumert T, Gut J-, Stoll-Keller F, Schvoerer E, Lambotin M. 330 Molecular Signatures Of Hepatitis C Virus Envelope Glycoproteins And Response To Antiviral Treatment Journal of Hepatology. 50. DOI: 10.1016/S0168-8278(09)60332-9 |
0.355 |
|
| 2008 |
Schramm F, Soulier E, Royer C, Weitten T, Fafi-Kremer S, Brignon N, Meyer N, Ellero B, Woehl-Jaegle ML, Meyer C, Wolf P, Doffoël M, Baumert TF, Stoll-Keller F, Schvoerer E. Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation. The Journal of Infectious Diseases. 198: 1656-66. PMID 18925843 DOI: 10.1086/592986 |
0.341 |
|
| 2008 |
Schramm F, Moenne-Loccoz R, Fafi-Kremer S, Soulier E, Royer C, Weitten T, Brignon N, Ellero B, Woehl-Jaegle M-, Meyer C, Wolf P, Doffoel M, Baumert T-, Gut J-, Stoll-Keller F, et al. Étude du leucotropisme du virus de l’hépatite C par analyse des quasi-espèces virales dans le contexte de la transplantation hépatique Pathologie Biologie. 56: 487-491. PMID 18842359 DOI: 10.1016/J.Patbio.2008.07.007 |
0.327 |
|
| 2008 |
Fafi-Kremer S, Zeisel MB, Schvoerer E, Soulier E, Habersetzer F, Wolf P, Doffoel M, Baumert TF, Stoll-Keller F. Anticorps neutralisants dirigés contre le virus de l’hépatite C Gastroenterologie Clinique Et Biologique. 32: 491-498. PMID 18467058 DOI: 10.1016/J.Gcb.2008.02.026 |
0.416 |
|
| 2008 |
Fafi-Kremer S, Morand P, Barranger C, Barguès G, Magro S, Bés J, Bourgeois P, Joannes M, Seigneurin JM. Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms. The Journal of Molecular Diagnostics : Jmd. 10: 78-84. PMID 18165270 DOI: 10.2353/Jmoldx.2008.070054 |
0.674 |
|
| 2008 |
Fafi-Kremer S, Soulier E, Fofana I, Carolla P, Bastien-Vale M, Schvoerer E, Schuster C, Schramm F, Cosset F-, Jaeck D, Doffoel M, Wolf P, Stoll-Keller F, Baumert T. 145 Viral Entry And Escape From Antibody-Mediated Neutralization Are Key Determinants For The Selection Of Hepatitis C Virus Variants During Liver Transplantation Journal of Hepatology. 48. DOI: 10.1016/S0168-8278(08)60147-6 |
0.358 |
|
| 2008 |
Lupberger J, Zeisel MB, Haberstroh A, Schnober EK, Krieger S, Soulier E, Thumann C, Royer C, Fafi-Kremer S, Schuster C, Stoll-Keller F, Blum HE, Baumert TF. Virus-host interactions during hepatitis C virus entry — implications for pathogenesis and novel treatment approaches Virologica Sinica. 23: 124-131. DOI: 10.1007/S12250-008-2943-X |
0.397 |
|
| 2007 |
Zeisel MB, Fafi-Kremer S, Fofana I, Barth H, Stoll-Keller F, Doffoel M, Baumert TF. Neutralizing antibodies in hepatitis C virus infection. World Journal of Gastroenterology : Wjg. 13: 4824-30. PMID 17828813 DOI: 10.3748/Wjg.V13.I36.4824 |
0.413 |
|
| 2007 |
Schvoerer E, Soulier E, Royer C, Renaudin AC, Thumann C, Fafi-Kremer S, Brignon N, Doridot S, Meyer N, Pinson P, Ellero B, Woehl-Jaegle ML, Meyer C, Wolf P, Zachary P, et al. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease. The Journal of Infectious Diseases. 196: 528-36. PMID 17624837 DOI: 10.1086/519691 |
0.357 |
|
| 2007 |
Ballout M, Germi R, Fafi-Kremer S, Guimet J, Barguès G, Seigneurin JM, Morand P. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression. Journal of Virological Methods. 143: 38-44. PMID 17368820 DOI: 10.1016/J.Jviromet.2007.02.005 |
0.663 |
|
| 2007 |
Payan C, Pivert A, Morand P, Fafi-Kremer S, Carrat F, Pol S, Cacoub P, Perronne C, Lunel F. Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients. Gut. 56: 1111-6. PMID 17363475 DOI: 10.1136/Gut.2006.106690 |
0.351 |
|
| 2006 |
Schvoerer E, Thumann C, Soulier E, Royer C, Fafi-Kremer S, Brignon N, Ellero B, Woehl-Jaegle M-, Meyer C, Wolf P, Jaeck D, Stoll-Keller F. Récurrence de l'infection par le virus de l'hépatite C (VHC) après transplantation du foie pour hépatopathie due au VHC : facteurs liés à l'hôte et facteurs viraux impliqués dans la survenue et la gravité de la récurrence de l'hépatite virale C Pathologie Biologie. 54: 556-560. PMID 17027191 DOI: 10.1016/J.Patbio.2006.07.027 |
0.391 |
|
| 2006 |
Pivert A, Payan C, Morand P, Fafi-Kremer S, Deshayes J, Carrat F, Pol S, Cacoub P, Perronne C, Lunel F. Comparison of Serum Hepatitis C Virus (HCV) RNA and Core Antigen Levels in Patients Coinfected with Human Immunodeficiency Virus and HCV and Treated with Interferon plus Ribavirin Journal of Clinical Microbiology. 44: 417-422. PMID 16455894 DOI: 10.1128/Jcm.44.2.417-422.2006 |
0.33 |
|
| 2006 |
Fafi-Kremer S, Amiel C, Coste-Burel M, Deback C, Gueudin M, Lafon M, Legoff J, Legrand M, Lependeven C, Leruez-Ville M, Mengelle C, Payan C, Pillet S, Nicolas J, Seigneurin J. Multicenter quality control study for the quantification of Epstein-Barr virus DNA in whole blood specimens Journal of Clinical Virology. 36: S29. DOI: 10.1016/S1386-6532(06)80806-1 |
0.665 |
|
| 2006 |
Payan C, Pivert A, Morand P, Fafi-Kremer S, Carrat F, Pol S, Cacoub P, Perronne C, Lunel F. P.235 Early virological response in HIV/HCV co-infected patients to IFN or Peg-IFN plus ribavirin assessed by HCV RNA measurement Journal of Clinical Virology. 36. DOI: 10.1016/S1386-6532(06)80415-4 |
0.328 |
|
| 2005 |
Fafi-Kremer S, Morand P, Germi R, Ballout M, Brion JP, Genoulaz O, Nicod S, Stahl JP, Ruigrok RW, Seigneurin JM. A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis. The Journal of Infectious Diseases. 192: 2108-11. PMID 16288374 DOI: 10.1086/498215 |
0.672 |
|
| 2005 |
Fafi-Kremer S, Zarski JP. [What tests should be prescribed in HBs-positive patients]. GastroentéRologie Clinique Et Biologique. 29: 364-8. PMID 15864196 |
0.491 |
|
| 2005 |
Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, Germi R, Genoulaz O, Nicod S, Jolivet M, Ruigrok RW, Stahl JP, Seigneurin JM. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. The Journal of Infectious Diseases. 191: 985-9. PMID 15717276 DOI: 10.1086/428097 |
0.693 |
|
| 2004 |
Germi R, Morand P, Brengel-Pesce K, Fafi-Kremer S, Genoulaz O, Ginevra C, Ballout M, Barguès G, Seigneurin JM. Quantification of gp350/220 Epstein-Barr virus (EBV) mRNA by real-time reverse transcription-PCR in EBV-associated diseases. Clinical Chemistry. 50: 1814-7. PMID 15388657 DOI: 10.1373/Clinchem.2004.034363 |
0.651 |
|
| 2004 |
Fafi-Kremer S, Brengel-Pesce K, Barguès G, Bourgeat MJ, Genoulaz O, Seigneurin JM, Morand P. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 30: 157-64. PMID 15125872 DOI: 10.1016/J.Jcv.2003.10.002 |
0.672 |
|
| Show low-probability matches. |